Skip to main content

Evaluation of a group acceptance commitment therapy intervention for people with knee or hip osteoarthritis: A pilot randomized controlled trial

APA Citation

Clarke, S. P., Poulis, N., Moreton, B. J., Walsh, D. A., & Lincoln, N. B. (2017). Evaluation of a group acceptance commitment therapy intervention for people with knee or hip osteoarthritis: A pilot randomized controlled trial. Disability and Rehabilitation, 39, 663-670. https://doi.org/10.3109/09638288.2016.1160295

Publication Topic
ACT: Empirical
Publication Type
Article
RCT
Language
English
Keyword(s)
Acceptance, osteoarthritis, pain, randomized controlled trial, Rasch
Abstract

Objectives: The aim was to evaluate an Acceptance commitment therapy (ACT) intervention for people with knee or hip osteoarthritis; a related aim was to compare treatment effects from Rasch-transformed and standard scales.

Methods: Participants were recruited from a research database and outpatient rheumatology and orthopaedic clinics at two hospitals. Eligible participants were randomly allocated to either intervention or usual care. Intervention comprised six-sessions of group ACT. Outcomes were assessed two and four months after randomization. Rasch-transformed and standard self-report measures were compared. Qualitative interviews also explored the acceptability of the intervention.

Results: Of 87 people assessed for eligibility, 31 (36%) were randomized. The main reason for non-randomization was that participants received surgery. Of the 16 participants randomized to intervention, 64% completed ≥50% of the scheduled group sessions. Follow-up data was complete for 84% participants at two months and 68% at four months. Outcome analysis demonstrated important differences between the Rasch-transformed and standard scales. There were significant differences between the groups in pain. Qualitative interviews with seven participants suggested the intervention was acceptable.

Conclusions: ACT for osteoarthritis is likely to be an acceptable treatment option for people with osteoarthritis. Progress to a definitive trial is warranted. Rasch-transformed outcome scales are preferable in clinical trials where possible.